Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India flag India · Delayed Price · Currency is INR
939.50
+13.15 (1.42%)
Sep 15, 2025, 3:30 PM IST

Aarti Pharmalabs Statistics

Total Valuation

NSE:AARTIPHARM has a market cap or net worth of INR 85.16 billion. The enterprise value is 88.73 billion.

Market Cap85.16B
Enterprise Value 88.73B

Important Dates

The next estimated earnings date is Tuesday, October 28, 2025.

Earnings Date Oct 28, 2025
Ex-Dividend Date Sep 15, 2025

Share Statistics

NSE:AARTIPHARM has 90.64 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class 90.64M
Shares Outstanding 90.64M
Shares Change (YoY) +0.05%
Shares Change (QoQ) -0.04%
Owned by Insiders (%) 29.03%
Owned by Institutions (%) 20.55%
Float 47.96M

Valuation Ratios

The trailing PE ratio is 31.98.

PE Ratio 31.98
Forward PE n/a
PS Ratio 4.38
PB Ratio 4.28
P/TBV Ratio 4.51
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 33.30
EV / Sales 4.56
EV / EBITDA 19.20
EV / EBIT 23.86
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.21
Debt / EBITDA 0.89
Debt / FCF n/a
Interest Coverage 12.95

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 10.51%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 9.00M
Profits Per Employee 1.23M
Employee Count2,162
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, NSE:AARTIPHARM has paid 860.15 million in taxes.

Income Tax 860.15M
Effective Tax Rate 24.40%

Stock Price Statistics

The stock price has increased by +42.60% in the last 52 weeks. The beta is -0.50, so NSE:AARTIPHARM's price volatility has been lower than the market average.

Beta (5Y) -0.50
52-Week Price Change +42.60%
50-Day Moving Average 888.17
200-Day Moving Average 774.20
Relative Strength Index (RSI) 64.75
Average Volume (20 Days) 332,344

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:AARTIPHARM had revenue of INR 19.46 billion and earned 2.66 billion in profits. Earnings per share was 29.38.

Revenue19.46B
Gross Profit 9.75B
Operating Income 3.74B
Pretax Income 3.52B
Net Income 2.66B
EBITDA 4.64B
EBIT 3.74B
Earnings Per Share (EPS) 29.38
Full Income Statement

Balance Sheet

The company has 562.06 million in cash and 4.13 billion in debt, giving a net cash position of -3.57 billion or -39.38 per share.

Cash & Cash Equivalents 562.06M
Total Debt 4.13B
Net Cash -3.57B
Net Cash Per Share -39.38
Equity (Book Value) 19.90B
Book Value Per Share 219.62
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 50.11%, with operating and profit margins of 19.20% and 13.69%.

Gross Margin 50.11%
Operating Margin 19.20%
Pretax Margin 18.11%
Profit Margin 13.69%
EBITDA Margin 23.84%
EBIT Margin 19.20%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.54%.

Dividend Per Share 5.00
Dividend Yield 0.54%
Dividend Growth (YoY) 66.67%
Years of Dividend Growth 2
Payout Ratio n/a
Buyback Yield -0.05%
Shareholder Yield 0.49%
Earnings Yield 3.13%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2